Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bogart

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2022
Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive ModelMichael Bogart, Yuhang Liu, Todd Oakland, et al.
Pulmonary Therapy|April 25, 2022
Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary DiseaseBenjamin Wu, David Mannino, George Mu, et al.
Respiratory Medicine|December 5, 2018
Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care settingMichael Bogart, Mrudula B Glassberg, Tyler Reinsch, et al.
Pulmonary Therapy|July 25, 2022
The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USAXavier Soler, James Siddall, Mark Small, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 15, 2022
Impact of Mepolizumab on Exacerbations in the US Medicare PopulationSanjay Sethi, Michael Bogart, Thomas Corbridge, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2024
Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium TherapyMichael Bogart, Gary Yat-Hung Leung, Anissa Cyhaniuk, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 31, 2023
Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United StatesMichael Bogart, Guillaume Germain, François Laliberté, et al.
Annals of Medicine and Surgery (2012)|September 4, 2023
Benign inoperable tracheal stenosis in COVID versus non-COVID patients at the pandemic epicenter: a case seriesMuhammad Perwaiz, Richard Durrance, Michael Bogart, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2022
Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient SurveyDavid Mannino, James Siddall, Mark Small, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 6, 2018
Impact of a pharmacist-led diabetes management on outcomes, utilization, and costDaniel D Maeng, Jove Graham, Michael Bogart, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2022
Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive ModelMichael Bogart, Yuhang Liu, Todd Oakland, et al.
Pulmonary Therapy|April 25, 2022
Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary DiseaseBenjamin Wu, David Mannino, George Mu, et al.
Respiratory Medicine|December 5, 2018
Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care settingMichael Bogart, Mrudula B Glassberg, Tyler Reinsch, et al.
Pulmonary Therapy|July 25, 2022
The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USAXavier Soler, James Siddall, Mark Small, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 15, 2022
Impact of Mepolizumab on Exacerbations in the US Medicare PopulationSanjay Sethi, Michael Bogart, Thomas Corbridge, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2024
Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium TherapyMichael Bogart, Gary Yat-Hung Leung, Anissa Cyhaniuk, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 31, 2023
Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United StatesMichael Bogart, Guillaume Germain, François Laliberté, et al.
Annals of Medicine and Surgery (2012)|September 4, 2023
Benign inoperable tracheal stenosis in COVID versus non-COVID patients at the pandemic epicenter: a case seriesMuhammad Perwaiz, Richard Durrance, Michael Bogart, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 14, 2022
Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient SurveyDavid Mannino, James Siddall, Mark Small, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 6, 2018
Impact of a pharmacist-led diabetes management on outcomes, utilization, and costDaniel D Maeng, Jove Graham, Michael Bogart, et al.
Pageof 4